Kazuyoshi Okada Selected Research

Gallium-67

3/2019	Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis.
1/2019	Pulmonary sarcoidosis as a cause of intermittent fever of unknown origin in a hemodialysis patient with renal cell carcinoma: A case report and literature review.
1/2018	Cilostazol-induced acute tubulointerstitial nephritis accompanied by IgA nephropathy: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuyoshi Okada Research Topics

Disease

21	Chronic Renal Insufficiency 01/2020 - 04/2009
12	Albuminuria 03/2015 - 01/2005
11	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 10/2002
8	Type 2 Diabetes Mellitus (MODY) 03/2019 - 06/2009
8	Anemia 06/2018 - 01/2006
7	Diabetic Nephropathies (Diabetic Nephropathy) 06/2016 - 01/2005
5	Proteinuria 06/2022 - 01/2005
5	Peritonitis 04/2021 - 06/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2021 - 07/2010
4	Infections 01/2021 - 11/2018
4	Inflammation (Inflammations) 01/2020 - 01/2011
4	Glomerulonephritis 05/2017 - 02/2007
4	Insulin Resistance 01/2011 - 06/2008
3	Fever (Fevers) 01/2022 - 01/2019
3	Atherosclerosis 01/2020 - 01/2011
3	Acute Kidney Injury (Acute Renal Failure) 01/2018 - 04/2010
3	Hypoglycemia (Reactive Hypoglycemia) 01/2015 - 01/2010
3	Body Weight (Weight, Body) 01/2005 - 01/2005
3	Hypertrophy 01/2005 - 01/2004
2	Disease Progression 01/2022 - 01/2012
2	Hypersensitivity (Allergy) 01/2022 - 01/2020
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Hyperplasia 01/2021 - 02/2006
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 03/2019 - 01/2018
2	Hematoma 01/2016 - 06/2011
2	Nephrosclerosis 01/2016 - 06/2013
2	Hypertension (High Blood Pressure) 01/2013 - 10/2009
2	Critical Illness (Critically Ill) 01/2011 - 04/2010
2	Diabetes Mellitus 09/2009 - 01/2005
2	Fibrosis (Cirrhosis) 01/2005 - 01/2004
1	Mycoses (Diseases, Fungus) 01/2022
1	Hypoalbuminemia 04/2021
1	Hyperparathyroidism 01/2021
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Abscess 01/2021
1	Secondary Hyperparathyroidism 01/2021

Drug/Important Bio-Agent (IBA)

8	Angiotensin Receptor AntagonistsIBA 07/2013 - 04/2009
6	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2005
6	Amlodipine (Norvasc)FDA LinkGeneric 07/2013 - 04/2009
4	oxidized low density lipoproteinIBA 06/2022 - 01/2011
4	C-Reactive ProteinIBA 01/2022 - 07/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 06/2016 - 01/2010
4	AldosteroneIBA 03/2015 - 02/2011
4	AlbuminsIBA 01/2015 - 01/2005
4	benidipineIBA 07/2013 - 04/2009
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2012 - 04/2009
4	LipidsIBA 01/2012 - 07/2010
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
3	Dialysis SolutionsIBA 01/2022 - 01/2011
3	Acetates (Acetic Acid Esters)FDA Link 01/2022 - 01/2011
3	Gallium-67IBA 03/2019 - 01/2018
3	Carnitine (L-Carnitine)FDA LinkGeneric 06/2017 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2005
3	Fatty Acid-Binding ProteinsIBA 03/2015 - 08/2011
3	Cystatin CIBA 01/2015 - 01/2011
3	Rosuvastatin Calcium (Crestor)FDA Link 01/2015 - 01/2011
3	CreatinineIBA 01/2015 - 09/2009
3	aliskiren FDA Link 07/2013 - 08/2012
3	Antihypertensive Agents (Antihypertensives)IBA 06/2013 - 10/2009
3	Insulin (Novolin)FDA Link 02/2013 - 06/2008
3	Erythropoietin FDA Link 01/2011 - 01/2006
3	AST 120IBA 01/2005 - 01/2004
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2022 - 09/2015
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2022 - 01/2020
2	Serum AlbuminIBA 04/2021 - 01/2016
2	MineralsIBA 01/2020 - 03/2013
2	alogliptinIBA 03/2019 - 02/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 04/2013
2	Interleukin-6 (Interleukin 6)IBA 04/2015 - 01/2011
2	olmesartanIBA 03/2015 - 08/2011
2	Blood Glucose (Blood Sugar)IBA 01/2015 - 01/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2015 - 02/2010
2	cilnidipineIBA 07/2013 - 09/2010
2	Hormones (Hormone)IBA 02/2013 - 01/2011
2	IncretinsIBA 02/2013 - 01/2011
2	Oxidants (Oxidizing Agents)IBA 08/2012 - 08/2011
2	AdiponectinIBA 01/2011 - 07/2010
2	Pioglitazone (Actos)FDA Link 07/2010 - 06/2009
2	Hemoglobins (Hemoglobin)IBA 07/2010 - 02/2010
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2009 - 09/2009
2	Losartan (Cozaar)FDA LinkGeneric 10/2009 - 09/2009
2	Uremic ToxinsIBA 01/2005 - 01/2004
1	SteroidsIBA 06/2022
1	GlucocorticoidsIBA 06/2022
1	CyclosporinsIBA 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	polyglucosanIBA 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2021

Therapy/Procedure

28	Renal Dialysis (Hemodialysis) 01/2021 - 10/2002
14	Therapeutics 06/2022 - 01/2004
7	Glycemic Control 01/2015 - 06/2008
6	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 04/2010
6	Peritoneal Dialysis 04/2021 - 01/2007
2	Blood Component Removal (Apheresis) 06/2022 - 09/2015
2	Catheters 01/2022 - 11/2018
2	Kidney Transplantation 01/2021 - 01/2013
2	Hemodiafiltration 01/2011 - 04/2010
2	Continuous Renal Replacement Therapy 01/2011 - 04/2010
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2006 - 10/2002
1	Parathyroidectomy 01/2021